CollPlant Biotechnologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLGN and other ETFs, options, and stocks.About CLGN
CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics.
CEOYehiel Tal
CEOYehiel Tal
Employees57
Employees57
HeadquartersRehovot, Tel Aviv
HeadquartersRehovot, Tel Aviv
Founded2004
Founded2004
Employees57
Employees57
CLGN Key Statistics
Market cap22.12M
Market cap22.12M
Price-Earnings ratio-1.61
Price-Earnings ratio-1.61
Dividend yield—
Dividend yield—
Average volume21.66K
Average volume21.66K
High today$1.63
High today$1.63
Low today$1.60
Low today$1.60
Open price$1.63
Open price$1.63
Volume2.48K
Volume2.48K
52 Week high$4.98
52 Week high$4.98
52 Week low$1.30
52 Week low$1.30
Stock Snapshot
CollPlant Biotechnologies(CLGN) stock is priced at $1.60, giving the company a market capitalization of 22.12M. It carries a P/E multiple of -1.61.
On 2026-01-14, CollPlant Biotechnologies(CLGN) stock moved within a range of $1.60 to $1.63. With shares now at $1.60, the stock is trading 0.0% above its intraday low and -1.7% below the session's peak.
Trading volume for CollPlant Biotechnologies(CLGN) stock has reached 2.48K, versus its average volume of 21.66K.
Over the past 52 weeks, CollPlant Biotechnologies(CLGN) stock has traded between a high of $4.98 and a low of $1.30.
Over the past 52 weeks, CollPlant Biotechnologies(CLGN) stock has traded between a high of $4.98 and a low of $1.30.
People also own
Based on the portfolios of people who own CLGN. This list is generated using Robinhood data, and it’s not a recommendation.